comparemela.com

Latest Breaking News On - Anthony hong - Page 1 : comparemela.com

Johnson & Johnson - What is cardiac ablation?

For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular.

United statesBrett gidneyBiosense webster cartoBiosense websterJohnson medtechAnthony hongFor american heart monthMapping systemVice presidentGlobal strategic marketingPulsed field ablationNews publishing

Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy

Approval based on data from REAL AF Registry, demonstrating value of real-world evidence

United statesJohnson medtechEmeliaj benjaminBiosense websterAnthony hongJose osorioBiosense webster incInternational stroke societyCardiovascular specialty solutionsCirculation researchPreclinical clinical researchResearch solutionsJournal of the american college cardiologyDrug administrationBi directional guiding sheathDensity mapping catheter

Biosense Webster ablation devices pick up new FDA approvals

Johnson & Johnson's Biosense Webster announced today that the FDA approved several products in its cardiac ablation portfolio.

Biosense websterBiosense webster pentarayJose osorioThermocool smarttouchAnthony hongCarto vizigoCardiovascular specialty solutionsResearch solutionsPentaray nav ecoJasmina brooksHeart rhythm clinicalSpecialty solutions

Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy

/PRNewswire/ Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced that several.

United statesEmeliaj benjaminJose osorioBiosense websterAnthony hongJohnson medtechNone of biosense webster incJournal of the american college cardiologyCardiovascular specialty solutionsPreclinical clinical researchInternational stroke societyResearch solutionsBiosense webster incCirculation researchExchange commissionPrnewswire biosense webster inc

First Look at Data on Biosense Webster s Investigational Pulsed Field Ablation Platform Presented at AF Symposium 2023

Late breaking analysis of one-year outcomes from the inspIRE clinical study demonstrated early success at the prespecified interim analysis

United statesViveky reddyJohnson medtechAnthony hongBiosense websterBiosense webster incArrhythmia servicesData monitoring committeeClinical researchMount sinai health systemCatheter program study advisory committeeInternational af symposiumMapping systemOne year outcomesAnnual internationalCardiac arrhythmia services

vimarsana © 2020. All Rights Reserved.